Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and 3'-deamino-3'-hydroxydaunorubicin

daunorubicin has been researched along with 3'-deamino-3'-hydroxydaunorubicin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, TM; Horton, D; Priebe, W; Turner, WR; Weckerle, W1
Horton, D; Priebe, W; Varela, O1
Alvord, WG; Gray-Goodrich, M; Jeffers, M; Kohlhagen, G; Koo, HM; McWilliams, MJ; Monks, A; Paull, KD; Pommier, Y; Vaigro-Wolff, A; Vande Woude, GF1
Koo, HM; Vande Woude, GF1
Bhagat, G; Dybkaer, K; Farnen, JP; Han van Krieken, J; Hsi, ED; Medeiros, LJ; Montes-Moreno, S; Møller, MB; O'Malley, DP; Ok, CY; Orazi, A; Piris, MA; Ponzoni, M; Richards, KL; Tzankov, A; Visco, C; Winter, JN; Xu-Monette, ZY; Young, KH; Zu, Y1

Other Studies

5 other study(ies) available for daunorubicin and 3'-deamino-3'-hydroxydaunorubicin

ArticleYear
Sugar-ring analogs of daunorubicin: 3'-epidaunorubicin, 3'-hydroxy-3',5'-diepidaunorubicin and 3',6'-dihydroxy-3',5'-diepidaunorubicin.
    The Journal of antibiotics, 1985, Volume: 38, Issue:5

    Topics: Animals; Antibiotics, Antineoplastic; Daunorubicin; Leukemia P388; Magnetic Resonance Spectroscopy; Mice

1985
3'-Deamino-4'-epi-3'-hydroxy-daunorubicin and -doxorubicin. Synthesis and antitumor activity.
    The Journal of antibiotics, 1984, Volume: 37, Issue:12

    Topics: Animals; Daunorubicin; Doxorubicin; Epirubicin; Leukemia P388; Mice; Structure-Activity Relationship

1984
The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
    Journal of the National Cancer Institute, 1999, Feb-03, Volume: 91, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Colonic Neoplasms; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Genes, ras; Humans; Mutation; Phenotype; Pyridines; Topoisomerase II Inhibitors; Transfection; Tumor Cells, Cultured

1999
Re: The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis.
    Journal of the National Cancer Institute, 1999, Nov-17, Volume: 91, Issue:22

    Topics: Antineoplastic Agents; Apoptosis; Carbazoles; Daunorubicin; Enzyme Inhibitors; Genes, ras; Humans; Neoplasms; Pyridines; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1999
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
    Cancer, 2014, Jun-15, Volume: 120, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal, Murine-Derived; Cyclin D1; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Female; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Mice; Middle Aged; Prednisone; Prevalence; Prognosis; Rituximab; Vincristine; Young Adult

2014